Massachusetts Cannabis Ballot Question 2026: What Voters Are Deciding

Executive summary

On November 3, 2026, Massachusetts voters will decide a statewide ballot question that could reverse part of the adult-use cannabis system they created in 2016. The Tufts Daily reported on October 13, 2026 that voters will weigh in on the future of the state's recreational marijuana laws. If the question passes, Massachusetts would become, to our knowledge, the first state to dismantle a operating adult-use retail market by popular vote.

The initiative targets the commercial side of the system: the licensed retail stores, cultivators and manufacturers regulated by the Cannabis Control Commission (CCC). Voters first legalized adult possession in 2016 by a margin of roughly 54% to 46%. The state's market has since generated well over $6 billion in cumulative sales, according to CCC data.

This hub is the evergreen reference for the question. It covers the history, the players, the legal framework under Article 48 of the Massachusetts Constitution, the regional competitive picture, and the business consequences for operators and investors. Readers should confirm the exact question number, summary language and effective-date provisions in the Secretary of the Commonwealth's official Information for Voters guide, because those details control what a "yes" or "no" vote does.

Three points matter most for operators and patients:

• The question is binary and takes effect on a statutory timeline set in the petition text, not by CCC rulemaking.
• Federal policy is moving in the opposite direction, toward Schedule III rescheduling and potential relief from 280E.
• The outcome will reset valuations for every Massachusetts-exposed MSO and independent licensee.

Why this matters

The vote touches a market of roughly $1.5 billion or more in annual sales, thousands of jobs, hundreds of licensed businesses and a municipal revenue stream that many Massachusetts towns now budget around.

Massachusetts is the largest adult-use market in the Northeast outside New York, and it draws heavy cross-border traffic from New Hampshire, which has no retail sales. Any change ripples through supply chains in Connecticut, Rhode Island, Maine and Vermont.

Stakeholders

• Consumers: adults who buy from licensed stores, and medical patients who share the same supply chain.
• Operators: multi-state operators, single-state vertically integrated licensees, craft cultivators, delivery licensees, and social equity and economic empowerment businesses.
• Municipalities: cities and towns collect up to a 3% local tax and negotiate host community agreements (HCAs).
• State government: the state collects a 10.75% excise tax plus the 6.25% sales tax on adult-use purchases.
• Public health and prevention groups: they argue commercialization increased access and potency.

The dollar frame

The maximum combined tax load on a Massachusetts adult-use sale is about 20%: 10.75% state excise, 6.25% sales tax, and up to 3% local option. Cannabis tax receipts have reached the hundreds of millions of dollars cumulatively since the first stores opened on November 20, 2018. The 2026 vote is therefore a fiscal question as well as a public health one.

Background and history

Massachusetts has legalized cannabis in three voter-driven steps (decriminalization in 2008, medical access in 2012 and adult use in 2016), each by ballot initiative under Article 48. The 2026 question is the first to run in the opposite direction.

2008: Question 2 decriminalizes possession

Voters approved Question 2 in November 2008 by about 65%. It converted possession of one ounce or less from a criminal offense to a civil infraction carrying a $100 fine. The vote showed that Massachusetts electorates were willing to bypass the Legislature on cannabis policy.

2012: Question 3 creates the medical program

Question 3 passed in November 2012 with roughly 63% support. It created the medical marijuana program and authorized registered non-profit dispensaries. The rollout was slow and contentious, and early dispensary licensing drew scrutiny. It still seeded the cultivation and retail expertise that later shaped the adult-use market.

2016: Question 4 legalizes adult use

On November 8, 2016, voters approved Question 4, the Regulation and Taxation of Marijuana Act, by about 53.7% to 46.3%. It legalized possession of up to one ounce in public and ten ounces at home, and allowed up to six plants per adult and twelve per household. It also set a 3.75% excise tax and created a regulatory structure under the State Treasurer.

2016-2017: The Legislature rewrites the law

In December 2016, lawmakers delayed retail by six months and raised the excise tax, producing the combined rate described above. In July 2017, the Legislature passed and Governor Charlie Baker signed Chapter 55 of the Acts of 2017, which created the independent five-member Cannabis Control Commission. Chapter 55 also gave municipalities a role: communities that voted against the 2016 question could ban retail by local vote, while others needed a local vote to opt out.

2018: Retail opens

The first licensed stores opened on November 20, 2018, in Leicester and Brookline. Rollout was gradual. Many municipalities banned or slow-walked retail, creating a patchwork that persists today. The state's first cohort of licensees leaned toward well-capitalized operators because of HCA costs, real estate prices and local-permitting delays.

2019-2021: Social equity and delivery

The CCC created a Social Equity Program and an Economic Empowerment Priority review track to give applicants from communities disproportionately harmed by prohibition a head start. It later created delivery-only licensing categories, including a delivery-to-consumer license reserved initially for equity and empowerment applicants. Results were uneven. Many equity applicants struggled to secure financing and host-community agreements.

2022-2024: Reform and price compression

Chapter 180 of the Acts of 2022 tightened host community agreement rules, capping community impact fees at 3% of gross sales for up to five years and strengthening oversight. Meanwhile, wholesale flower prices fell as cultivation capacity expanded, putting pressure on margins. The CCC also approved pilot rules for social consumption sites.

In November 2024, voters rejected a separate ballot question, Question 4, which would have decriminalized certain natural psychedelics. The vote was widely read as a sign of voter caution about further drug-policy liberalization.

2025-2026: The repeal petition

Under Article 48, initiative proponents must file with the Attorney General, obtain certification, gather an initial round of signatures (about 75,000 for the 2026 cycle), give the Legislature until early May to act, and then collect a second, smaller round of roughly 12,000 additional signatures. Attorney General Andrea Campbell certified a cannabis-related petition in the 2025 filing round. The petition cleared the signature steps and was placed on the November 3, 2026 ballot.

Federal backdrop

Federal developments run in parallel. The DEA's rescheduling process, the 2024 NPRM proposing Schedule III, and a December 2025 executive order from President Trump directing expedited action have all raised the prospect of relief from 280E. Congress also adopted a restriction on intoxicating hemp-derived products in the November 2025 funding law, with a delayed effective date in November 2026. That date falls days after the Massachusetts vote.

Key players

The campaign pits public-health and prevention advocates, plus some municipal voices, against the licensed industry, social equity operators and legalization advocates. Campaign committees, funders and endorsements are on file with the Massachusetts Office of Campaign and Political Finance (OCPF), which is the best source for current money data.

Cannabis Control Commission

The CCC is the independent regulator of the adult-use and medical markets. It licenses cultivators, product manufacturers, retailers, couriers and testing labs, and it publishes weekly sales data. If the question passes, the CCC would be the agency managing wind-down or transition steps, depending on the text.

Attorney General Andrea Campbell

Her office certifies initiative petitions as constitutionally eligible and writes the one-sentence summaries that appear on petitions. Summary language often becomes a point of litigation before the Supreme Judicial Court.

Secretary of the Commonwealth

The Secretary's office administers signature certification, assigns question numbers and publishes the Information for Voters guide, which includes the full petition text, a 150-word statement from each side and the Attorney General's fiscal summary.

The Legislature

Lawmakers had the option of enacting the petition's substance or a compromise before the second signature round. They did not, so the question went to voters. Legislative leaders remain central to any post-vote implementing legislation.

Governor Maura Healey

The governor appoints CCC commissioners (with the Attorney General and Treasurer) and would sign or veto follow-on legislation. A repeal vote does not require her signature.

Smart Approaches to Marijuana (SAM)

SAM, led by president Kevin Sabet, is the leading national organization opposed to commercial cannabis. It argues that commercialization raises potency, advertising exposure and youth use. It has been a visible ally for restrictions in several states.

Industry and advocacy groups

Trade groups representing licensed Massachusetts operators, social equity businesses and national advocates such as NORML oppose repeal. They argue that ending licensed sales would revive illicit-market activity, eliminate jobs and forfeit tax revenue. MSOs with Massachusetts footprints have a direct stake in the outcome.

Municipalities

Cities and towns are split. Some host large retail clusters and depend on community impact fees. Others have banned retail and view repeal as consistent with local choices. The Massachusetts Municipal Association is a useful source on local positions.

Legal and regulatory framework

The vote operates under Article 48 of the Massachusetts Constitution, but the underlying product remains a Schedule I controlled substance under federal law, 21 U.S.C. § 812, until rescheduling is finalized.

State law

• Chapter 94G of the Massachusetts General Laws: the Regulation of the Use and Distribution of Marijuana Not Medically Prescribed. This is the statute created by Question 4 and amended by the Legislature. Its provisions would be the focus of any repeal text.
• Chapter 94I: the medical-use framework, which has operated separately since the 2017 law folded medical oversight into the CCC.
• Chapter 55 of the Acts of 2017: established the CCC.
• Chapter 180 of the Acts of 2022: reformed host community agreements.
• 935 CMR 500 and 501: the CCC's regulations for adult-use and medical operations.

Article 48 and the initiative process

Article 48 allows citizens to propose laws by initiative petition. The Attorney General must certify that a petition meets constitutional requirements. Article 48 bars initiatives on certain subjects, and the Supreme Judicial Court has reviewed challenges, including questions about whether petition provisions are "related or mutually dependent." A passing initiative becomes law 30 days after the Governor's proclamation of the election result unless the petition specifies otherwise. The Legislature retains the power to amend or repeal statutes enacted by initiative, subject to political reality.

Federal law

Marijuana remains in Schedule I of the Controlled Substances Act. The DEA and the Department of Justice have been in a rescheduling process that began with a 2024 NPRM proposing Schedule III. Hearings before an ALJ were postponed and the process stalled before the December 2025 executive order. Schedule III would not make state-licensed sales federally legal, but it would remove the 280E tax penalty for plant-touching businesses. The FDA role centers on the scientific and medical review underpinning